Testing of nomela® on images confirmed as melanoma

Testing of nomela® on images of skin lesions confirmed as cutaneous melanoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN63318109

Enrollment

Registered

2018-01-18

Start date

2018-08-02

Completion date

Unknown

Last updated

2021-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cutaneous melanoma Cancer Cutaneous melanoma

Interventions

There is no direct involvement of participants. In effect there is no enrolment nor participation except that participants are being asked to widen the scope of consent so that the use of images of th

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age 16 years and over 2. Having a confirmed diagnosis of cutaneous melanoma in NHS Lanarkshire

Exclusion criteria

Exclusion criteria: 1. Unable or unwilling to give informed consent 2. Aged less than 16 years

Design outcomes

Primary

Measure	Time frame
Sensitivity is measured against reference ranges defined in previous range-finding study (Moletest004) note that specificity will not be available in this study.	—

Secondary

Measure	Time frame
There are no secondary outcome measures	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026